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Abstract
This narrative review examines connections between neurology, specialist palliative care, and 
an integrated palliative approach to care for people living with neurodegenerative conditions. 
To illustrate the complexities of including palliative care in the management of neurodegenerative 
conditions, amyotrophic lateral sclerosis (ALS) is used as a case study. Challenges to co-ordinated 
ALS care and smooth care transitions between multiple services and healthcare professionals are 
discussed, including the timing of palliative care delivery in ALS; the education and training needs 
of healthcare professionals; and misperceptions of palliative care held by healthcare professionals, 
patients, and families. The benefits of adopting an integrated palliative approach to care for 
patients, families, and healthcare professionals are clarified. To enhance this, a family perspective 
is given on experiences of ALS neurology and palliative services, the challenges they faced, and 
This thoughtful, clinically relevant narrative review from  
Hogden et al. discusses the importance of an integrated  
palliative approach to care for people living with neurodegenerative  
conditions, using amyotrophic lateral sclerosis (ALS) as an example of the 
complexities involved.  The importance of palliative care in the management 
of neurodegenerative disease is a hot topic that deserves to be more openly 
discussed, and specialist palliative care services need to include the full scope of 
health and community-based care. This review will be of interest not only to ALS 
specialists but also to neurology health professionals within the wider community 
and will allow readers to reflect on their own practices.
Samantha Warne
Editor
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BACKGROUND
The World Health Organization (WHO) 
defines palliative care as “…an approach that 
improves the quality of life of patients and their 
families facing the problem associated with 
life-threatening illness, through the prevention 
and relief of suffering by means of early 
identification and impeccable assessment and 
treatment of pain and other problems, physical, 
psychosocial and spiritual.”1 People living 
with neurodegenerative disorders receive 
diagnostic, therapeutic, and end-of-life care from 
neurology and palliative care services. While 
these two disciplines may seem disparate, their 
goals for this patient group are aligned. As the 
Association of British Neurologists (ABN) states, 
its mission is to “…improve the health and 
wellbeing of people with neurological disorders 
by advancing the knowledge and practice of 
neurology in the British Isles”.2 The overlapping 
aims of neurology and palliative care combine 
when teams collaborate to improve the lives 
and care of people with neurodegenerative 
conditions such as Parkinson’s disease, multiple 
sclerosis, Huntington’s disease, and amyotrophic 
lateral sclerosis (ALS).3 Even so, non-malignant 
diseases such as these neurodegenerative 
conditions are under-represented in palliative 
care. A recent national Australian survey found 
that more people with cancer (64%) had 
received palliative care in comparison to 
non-malignant illnesses (4–10%),4 echoing results 
of a study conducted 10 years prior.5
Although diagnostic, therapeutic, and 
palliative care services operate from different 
perspectives, there are synergistic relationships 
between the neurology and palliative care 
teams.6 This narrative review uses ALS as 
a case study to comprehensively explore 
the relationship between these disciplines.7 
This style of review was selected as the optimal 
way to delve deeply into this issue and uncover 
gaps between evidence, opinion, and practice. 
The aims of this review were to consider 
how patients benefit from an integrated 
interdisciplinary approach and to reveal how 
collaboration between neurology and palliative 
care teams can be strengthened. 
COMPLEX CARE FOR  
A COMPLEX DISEASE
The complexity of ALS and the subsequent 
impact of a diagnosis on patients and their 
families highlight both the interconnectedness 
of, and disparities between, neurological, 
therapeutic, and palliative care of patients 
throughout the disease course. As with many 
other neurodegenerative conditions, ALS lacks 
a cure or an effective disease-slowing treatment 
with significant benefit. Death most frequently 
occurs from respiratory failure 2–4 years after 
symptom onset, although a small proportion 
of patients (estimated to be around 5–10%) live 
for ≥10 years.8 The presentation of the disease 
and the speed at which it progresses varies 
considerably between individuals.9 Physical 
symptoms can include changes in mobility, 
limb strength, speech, voice, swallowing, 
and respiratory function, and many people 
will also experience mild changes of varying 
severity in behaviour, memory, and thinking 
skills.10-12 A minority of patients will present with 
frontotemporal dementia,10 with or without 
accompanying physical symptoms. While a small 
number have an inherited form of the disease,13,14 
for most, the cause is unknown.
aspects of care that facilitated the patient’s preferences for the time they had left. This review 
concludes that a palliative approach integrated into the care plan of people with ALS from the time 
of diagnosis can optimise quality of life by relieving symptoms; providing emotional, psychological, 
and spiritual support pre-bereavement; minimising barriers to a comfortable end of life; and 
supporting the family post-bereavement. These outcomes can only be achieved if palliative care 
knowledge and expertise are extended beyond the domain of specialist palliative care services to 
include the full scope of health and community-based care. These challenges and potential actions 
are common for several neurodegenerative pathologies, and recommendations are made for 
enhancing the training of neurology health professionals within the wider community.
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RECEIVING A DIAGNOSIS
The complexity of ALS care begins with 
obtaining a diagnosis, and a timely and definitive 
diagnosis is an ongoing concern for patients 
and clinicians.15 It is important for neurologists 
to make a definite diagnosis rather than an 
early but tentative diagnosis. Establishing the 
diagnosis with certainty often requires periods 
of observation of symptom development 
and evolution of the clinical signs. Making an 
ALS diagnosis too early can cause enormous 
anxiety for patients and families, especially if 
a tentative diagnosis is incorrect. On the other 
hand, delays in obtaining a diagnosis can put 
patients at risk of depression,16 unnecessary 
interventions such as spinal surgery,15 and 
unnecessary clinical consultations.15,17
COMMUNICATING THE DIAGNOSIS
Many neurologists report being uncomfortable 
and inadequately trained to sensitively 
communicate an ALS diagnosis,18 adding to 
patient and carer anxiety.19-21 Moreover, in a 
recent Australian study, nearly 40% of 
patients and family carers were dissatisfied 
with the way they received the diagnosis.19,20 
Greater adherence to effective communication 
techniques when delivering bad news, 
particularly displaying empathy, may improve 
the way neurologists perform this difficult task. 
Targeted educational programmes and the 
development of best practice protocols may 
go a long way to making these improvements 
attainable. Additionally, the diagnosis of ALS 
is frequently given by a neurologist outside of 
a multidisciplinary clinic (MDC) environment 
and without the involvement of specialised 
ALS services. Referral to specialised ALS and 
palliative care services can then be delayed until 
after a second opinion has been received.
Once a diagnosis is obtained, the continual 
progression of ALS creates further challenges 
to the delivery of co-ordinated patient care. 
Issues include timely provision of treatment and 
equipment22 and assessment of end-of-life care 
in line with patients’ preferences.23 Disruptions 
Figure 1: Interdisciplinary model of care for people living with amyotrophic lateral sclerosis. 
ALS: amyotrophic lateral sclerosis. 
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to service delivery can lead to fragmented 
care and put patient quality of care and quality 
of life at risk; this is a frequent concern 
raised by patients,24 family members,25-27 and 
health professionals.28 
MODELS OF CO-ORDINATED CARE
In response to these challenges, specialised ALS 
care requires co-ordinated and multifaceted 
service delivery to address the variability of 
clinical presentations and patients’ continually 
changing needs. The multidisciplinary model 
of care (i.e., teams remaining within their 
boundaries to work with the patient), developed 
to provide comprehensive and evidence-
informed patient care,29,30 has evolved into an 
interdisciplinary model (i.e., care teams working 
in an interactive, co-ordinated, and coherent 
way to provide patient care)31 as the spectrum 
of care for patients with ALS has broadened.32 
Furthermore, the focus of care has become more 
patient-centric and the team that assembles 
around the patient and their family to provide 
care may be individualised to reflect the patient’s 
preferences. Thus, ALS patient teams can now 
include clinical care from medical, nursing, 
and allied health professionals from neurology, 
palliative care, rehabilitation, gastroenterology, 
respiratory medicine, and psychiatry, working 
alongside support services such as ALS support 
associations,33 genetic counselling,13 and pastoral 
care (Figure 1). Patients and families may also 
access assistance from government agencies, 
community services, and national ALS information 
and support services, and patients may integrate 
complementary therapies, such as massage, 
to assist their wellbeing. Guidelines recommend 
that clinical care is delivered through specialised 
ALS MDC to ensure care is well co-ordinated 
between healthcare disciplines and ALS support 
organisations where available.29 Specialised 
ALS MDC have been shown to provide effective 
care that can prolong patient survival time.34 
INTEGRATING PALLIATIVE CARE  
INTO MULTIDISCIPLINARY CLINICS
There is increasing evidence that incorporating 
palliative care in MDC care, as shown in 
Figure 1, leads to improved symptoms and 
quality of life of people with ALS and their 
families.3,35,36 Even so, the timing of discussions 
of the concept of palliative care with ALS 
patients and when they are referred to and 
receive palliative care services is contentious. 
Introducing newly diagnosed patients to the 
concept of palliative care is a challenge for health 
professionals and can create tension between 
ALS therapeutic and palliative services that is 
often unresolved.37 Guidelines recommend that 
ALS patients are referred to palliative services 
early in the disease course to improve the 
patient’s quality of life,36,38,39 but patients, families, 
and health professionals may not be ready to 
discuss this type of care for some time. 
Another view is that patients should be referred 
to palliative care once particular ALS disease 
milestones have been reached. However, 
referrals to palliative care are often triggered by 
crisis situations,40,41 resulting in care that is too 
little and too late.28 There is disparity between 
patient, carer, and health professional views on 
when and how end-of-life discussions should 
be conducted.42 Patients and family members 
may become distressed when end-of-life issues 
are raised,24,25 equating the topic with the end 
of hope. Many diagnostic and therapeutic 
health professionals feel unprepared to 
discuss end-of-life care, particularly with 
newly diagnosed patients.40,42 The potential 
consequences of avoiding palliative interventions 
also conflict with patient wishes for a peaceful 
death,43 as patients who are unable to access 
well-timed palliative interventions risk an 
uncomfortable death through poorly controlled 
respiratory problems, pain, and anxiety.44 The 
authors consider that a better way to integrate 
palliative care services into ALS care is to adopt 
a palliative approach to care, and this approach 
is elaborated below.
ADOPTING A PALLIATIVE  
APPROACH TO AMYOTROPHIC 
LATERAL SCLEROSIS CARE
The original intent of palliative care was as a 
philosophy of and approach to care; however, 
palliative care has now become more equated 
with service provision that focusses on the last 
months and weeks of life. A palliative approach 
to care begins at the time of diagnosis and 
does not link care provision too closely with 
prognosis, instead promoting early interventions 
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for patients and their family members, aligned 
to their goals of care, comfort measures, and 
needs and wishes.45,46 The Worldwide Palliative 
Care Alliance (WPCA)47 has also suggested that 
a palliative care approach be adopted by all, 
not just specialist healthcare professionals, 
and that general palliative care be provided 
by primary care professionals who have an 
understanding of palliative care principles.
It is important to delineate the palliative care 
approach from specialist services since both 
operate at different stages of the disease 
trajectory. A palliative approach45 in ALS 
emphasises patient and family-centred care 
that focusses on the person and not just 
the disease, the importance of therapeutic 
relationships between care providers and 
the patient and their family, and clear 
communication throughout the illness trajectory; 
in particular, the approach is based on the goals 
of care and advance care plans (ACP) (Box 1).48
There is increasing evidence that a palliative 
approach integrated into ALS multidisciplinary 
care leads to improved symptoms and quality 
of life of people with ALS and their families.3 
Integrated into the care plan for people with 
ALS from the time of diagnosis, a palliative 
approach can optimise quality of life by relieving 
symptoms; providing emotional, psychological, 
and spiritual support pre-bereavement; 
minimising barriers to a comfortable death; 
and supporting the family post-bereavement. 
These outcomes can only be achieved if 
palliative care knowledge and expertise are 
extended beyond the domain of specialist 
palliative care services to include the full scope 
of health and community-based care services, 
mostly at home, to meet the extensive range of 
needs of people living with ALS and their 
families. In most instances, a palliative approach 
to care can be provided in the community, 
supported by knowledgeable health professionals, 
and lasts for the duration of the disease. 
Admission to a specialised palliative care 
inpatient facility may only occur during brief 
episodes of care, such as respite, symptom 
management, or terminal phase of illness,49 or 
may be required for intractable symptoms or 
in a crisis.45 However, the home is the preferred 
place of care for many patients.50,51 The palliative 
approach supports this by offering care 
delivered in the environment of the patient’s 
choice; control of symptoms, including medication 
for sleep, depression, anxiety, and distress; 
patient choice and control over management; 
holistic care; support for both the patient and 
their family throughout caregiving;26 and ongoing 
bereavement support for the family as needed.52 
Barriers to Integrating  
a Palliative Approach
Barriers to integrating a palliative approach 
into ALS care arise from limited understanding 
of what palliative care offers, the availability 
of care beyond the hospice, and the 
effectiveness of palliative interventions for 
ALS.37,50 They include the belief that a palliative 
approach is only appropriate for end-of-life, 
lack of recognition that a person is terminally 
ill, health professionals’ lack of knowledge or 
interest in a new approach, discomfort with 
discussing the need for palliative care,45 and 
concern about resource and funding issues. 
Overcoming these barriers involves educating 
health professionals, patients, and families 
(and the wider community) about the benefits 
of a palliative approach integrated into 
neurodegenerative disease care. As discussions 
about using a palliative approach can begin at 
any time, it can be gradually adopted so 
that changes to care are not abrupt. Health 
professionals can ensure that patients and 
families understand that other services, including 
neurology and rehabilitation, will continue 
alongside palliative services. In ALS, care 
transitions may be confusing and frightening53 
because they often signal deterioration in the 
patient’s condition, from which there is no 
improvement. To fully integrate a palliative 
approach and to ensure transitions are seamless, 
education and training in integrating palliative 
care need to be provided to all health and 
community service providers involved in ALS 
care; education and training in the care needs 
of people with ALS should also be given to 
palliative care service providers. Educational 
programmes to improve the knowledge of 
health professionals about a palliative approach 
in ALS care have been recently implemented.54
Alongside a palliative approach to care, another 
integrated model of care for people with ALS 
has emerged.55 Neuropalliative rehabilitation 
is a speciality that recognises the intersection 
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between neurology, rehabilitation, and palliative 
care services. The aims of this approach are 
to promote quality of life through proactive 
symptom management and may involve a 
broad range of health disciplines, such as 
music therapy.56 The objectives of neuropalliative 
rehabilitation are to prevent secondary 
complications, provide an environment for 
promoting patient health, allow treatment and 
modification of the disease (where possible), 
help the patient adapt to their altered 
circumstances, modify the patient’s environment 
to promote safety and quality of life, and 
support the family.55 Neuropalliative rehabilitation 
is particularly appropriate for people with rapidly 
progressive disease and those with distressing 
symptoms.55 While neuropalliative rehabilitation 
shares many of the benefits of a palliative 
approach, it is less easily integrated into non-
specialist ALS services in the wider community, 
where many patients who are unable to attend 
MDC receive their care.
ALS: amyotrophic lateral sclerosis; HP: healthcare providers; MDC: multidisciplinary clinics.
Adapted from Warren et al. in Oliver et al.59
Disease 
stage
Aims Challenges Enablers
Early  > Focussing on  
making the most of 
the time remaining.
 > Leaving a  
lasting legacy.
 > Being able to die  
at home.
 > Health system constraints restricting 
HP to immediate issues.
 > Transition to palliative care should  
have begun at this point, rather  
than at end stage.
 > Direct and honest communication  
with neurologist.
 > Equipping and adapting the home  
to meet patient’s long-term needs.
 > Information to prepare the family  
for what was to come.
 > Strong relationships with HP  
and ALS support association.
 > HP anticipating future issues.
 > Advance care planning.
Mid No specific aims.  > Delayed acquisition of equipment.
 > Fatigue and overload attending ALS 
clinic; need for real-time  
information sharing.
 > Care and respite workers’ lack of 
understanding of ALS and training  
in palliative care approaches.
 > System constraints for service provision.
 > Information, resources,  
and support from ALS  
support association.
End  > Receive all services  
at home.
 > Establishing new relationships  
with palliative home-based  
care team.
 > Self-care for carers.
 > Accessing information on  
palliative sedation.
 > Family providing personal and 
overnight care.
 > HP working across ALS MDC  
and palliative care teams.
 > Direct and honest information from 
ALS and palliative care team.
Box 1: Essential characteristics of a palliative approach.48
 > An upstream orientation to care: early on in the illness trajectory, even as soon as the time of diagnosis. 
 > An emphasis on anticipatory planning and open conversations about goals of care.
 > An adaptation of palliative care knowledge and expertise by primary care professionals.
 > An operationalisation of a palliative approach through integration and contextualisation within  
healthcare systems.
 > Promote better service planning, better care, and better outcomes for patients and their family members.
 Table 1: A family’s perspectives on integrated care from diagnosis to bereavement.
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FAMILY CARERS AS PARTNERS  
IN A PALLIATIVE APPROACH  
TO AMYOTROPHIC LATERAL 
SCLEROSIS CARE
Family carers are vital partners in a palliative 
approach to care. As the patient becomes 
more physically dependent, family members 
provide logistical and hands-on care, as well 
as emotional support.25 A range of health 
professionals work closely with the patient and 
family to ensure effective care from diagnosis 
to the end of life.57 ALS service experiences of 
people living with ALS and their carers have 
provided insight into how quality of care is 
perceived.24,25,27,51,58 A published example from 
one family revealed how a palliative approach 
to care was perceived through the care aims, 
challenges, and enabling aspects encountered 
during their family member’s ALS journey.51 
Their story, summarised in Table 1, reveals the 
benefits of an integrated palliative approach 
and how planning for a comfortable death can 
co-exist with living each day to the fullest.59
A second example has highlighted the ongoing 
support and education for family carers as a 
further benefit of integrated approaches to 
care. The family, and in particular the primary 
family carer (most often the spouse who may 
act as a substitute decision maker), should 
be informed about all options throughout the 
disease course and be prepared for the 
impending loss of their loved one. This aims 
to minimise their psychological burden when 
they are asked to make existential decisions 
they are rarely well-equipped to make, and, 
as a consequence, reduce adverse outcomes 
such as complicated grief, which can continue 
through the bereavement stage.27,52 To this end, 
an Australian ALS support association has trialled 
the use of a person-centred international 
validated tool, the Carer Support Needs 
Assessment Tool (CSNAT), which creates 
the opportunity for systematically holding 
conversations about the practical, psychological, 
spiritual, and existential needs of carers in 
supporting their care recipients and helping 
themselves.60 Like the family account given in 
Table 1, the highest support priorities of ALS 
family carers were knowing what to expect in 
the future, knowing who to contact if concerned, 
equipment to help care, and dealing with 
feelings and worries. For the priority of knowing 
what to expect in the future, discussions with 
service providers covered end-of-life issues, 
advance health directives, future care, and 
the role of palliative care.59 This demonstrates 
an integrated palliative approach to care and 
its focus on patient and family needs.
Around the time of end of life, it is common 
for people with ALS to refuse life-sustaining 
treatment. Decisions for end-of-life care, including 
the use and withdrawal of ventilation and 
nutrition, need to be discussed with the patient 
and family proactively in advance of deterioration. 
It is important that patients and families 
determine their preferences and that these 
decisions are documented in an advance health 
directive or an ACP. However, the uptake of such 
documents is still low worldwide, ranging from 
10–25%, though those who received palliative 
care were two to three-times more likely to have 
an advance health directive or ACP in place.4
Despite the inevitability of death associated 
with an ALS diagnosis, many families do not 
receive bereavement support. For example, an 
Australian study of ALS family carers reported 
that half of participants did not recall receiving 
offers of bereavement support and over one-
third of the sample met criteria for prolonged 
grief disorder, a much higher proportion than 
the general population estimate of 10%.22 
On average, palliative care services were 
received <2 months before patient death.22 
The benefits gained by family carers in being 
engaged in early and direct assessment of 
their support needs before bereavement53 
reinforce the need for palliative care services to 
effectively support carers well before the patient’s 
death.4,45 A continuum of support between 
caregiving and bereavement lends itself well to 
palliative care services that have the opportunity 
to investigate grief and bereavement support in 
the lead up to the patient’s death.4,45 This is 
more achievable with a palliative approach that 
can be initiated earlier in the disease journey, 
allowing a rapport to develop between the 
family carers and the relevant professionals 
within the interdisciplinary care team.
CONCLUSION
Every person with a life-limiting illness has 
a fundamental right to a palliative approach 
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